(Allergan plc)

	AGN latest price $175.7900 (0.66%) ($174.4300 - $176.0000) on Wed. Oct. 30, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.62% (three month average)
RSI	89
Latest Price	$175.7900(0.66%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 1.4% a week on average for past two weeks.
Market Behavior	Growth stock rally for large cap. Value stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IVW(85%)    IWF(85%)    VUG(85%)    XLC(85%)    IBB(84%)
Factors Impacting AGN price	AGN will decline at least -0.31% in a week (0% probabilities).   VXX(-73%)    VIXM(-62%)    TLT(-44%)    BWX(-13%)    IGOV(-9%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.31% (StdDev 0.62%)
Hourly BBV	0 ()
Intraday Trend	0.5%

5 Day Moving Average	$174.48(0.75%)
10 Day Moving Average	$174.35(0.83%)
20 Day Moving Average	$171.56(2.47%)
To recent high	0%
To recent low	12.4%
Market Cap	$57.958b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed